SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CVTX - CV Therapeutics, Inc.
An SI Board Since January 1999
Posts SubjectMarks Bans
411 31 0
Emcee:  Todd N. Weisrock Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
111Well meaningless is too strong a term. The fact that the FDA felt an AC meeting Biomaven-11/3/2003
110Thanks for correcting me. From what you say it seems that the conditional approA.J. Mullen-11/3/2003
109<i>Isn't that odd?</i> The whole situation is very unusual. NorBiomaven-11/3/2003
108Isn't that odd? I thought the FDA issued approvable, then the committee recA.J. Mullen-10/31/2003
107CV Therapeutics Receives Approvable Letter for Ranexa(TM) Thursday October 30, 5mopgcw-10/30/2003
106CV Therapeutics Initiates Phase III Trial of CVT-3146 Tuesday October 28, 6:23 pmopgcw-10/28/2003
105Lehman report CV Therapeutics (CVTX - $18.88) 2-Equal weight Current BVPS 6.43 mopgcw-10/24/2003
104Review Date Is Big News for CV Therapeutics <i>(From The Street) </i>A.J. Mullen-10/23/2003
103CV Therapeutics Reports 2003 Third Quarter Financial Results Friday October 17, mopgcw-10/20/2003
102CVTX CC part 2 Lange, CV Therapeutics - Chairman, CEO [13] ----------------mopgcw-10/19/2003
101Final Event Transcript of CVTX conference call, 17-Oct-03 9:00am 2003-10-17 15:0mopgcw-10/19/2003
100UPDATE - CV Therapeutics files $252.5 mln mixed shelf Friday October 3, 6:47 am mopgcw-10/6/2003
99J Am Coll Cardiol. 2003 Sep 17;42(6):1098-102. Termination of paroxysmal suprscaram(o)uche-9/25/2003
98Replay of BSC presentation: customer.nvglb.commopgcw-9/10/2003
97CV Therapeutics Announces Ranexa(TM) Abstracts to Be Presented 2003-08-20 16:30 mopgcw-8/22/2003
96Bound to happen, but still a sad commentary: Holder Suit Filed Against CV Themopgcw-8/8/2003
95Jim, It is a long story, going back to 98/99/00, and early. R was tested for sMiljenko Zuanic-8/5/2003
94Miljenko, do you think the issue is whether Ranexa is to be approved only for paJim Haynes-8/4/2003
93Appears (to me) that street is not overly concerned about R NDA and that it is oMiljenko Zuanic-8/4/2003
92An even earlier indicator: Message 19102161 Bravo. You clearly called it agaimopgcw-8/4/2003
91As you can see, and early indicator was: Message 19136353 Press Release SourceMiljenko Zuanic-8/2/2003
90Very strange activity in Oct puts. Price jumped all over the place???Miljenko Zuanic-7/23/2003
89yesMiljenko Zuanic-7/11/2003
88and you have doubts?mopgcw-7/11/2003
87First, it has to pass AC, than FDA, than to market. This explain their cash neeMiljenko Zuanic-7/10/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News